Clinical Trials Sponsored by Fliegerärztliches Institut

Total 74713 results

Toronto Rehabilitation Institute
Canadian Institutes of Health Research (CIHR)

Unknown

Fit for Dialysis: Research-based Film as a Knowledge Translation Strategy

End-Stage Renal Disease

Canada
OHSU Knight Cancer Institute
National Institutes of Health (NIH)

Completed

CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

Cervical Cancer | Breast Cancer | Colorectal Cancer

United States
National Cancer Institute (NCI)
National Institutes of Health (NIH)

Completed

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer

United States
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
Istituto Giannina Gaslini
Bambino Gesù Hospital and Research Institute

Terminated

Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome

Nephrotic Syndrome Steroid-Dependent

Italy
Children's National Research Institute
National Institutes of Health (NIH)

Completed

MRI Assessment of Arrythmia Ablation Lesions

Ventricular Tachycardia | Cardiac Arrhythmia

United States
Cancer Prevention and Research Institute, Italy
Istituto Toscano Tumori

Unknown

Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women

Cervical Cancer

Italy
Italian Institute of Telemedicine
Istituto Auxologico Italiano; Bracco Corporate

Completed

Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants (TELEBPMET)

Metabolic Syndrome | Arterial Hypertension

Italy
Bruyere Research Institute
Canadian Institutes of Health Research (CIHR)

Unknown

The PIP-STOPP Study (PIP-STOPP)

Potentially Inappropriate Prescribing (PIP)
Istituto Scientifico H. San Raffaele

Unknown

Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma

Brain and Central Nervous System Tumors

Italy
Istituto Scientifico H. San Raffaele

Unknown

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer

Italy
National Institute of Hygiene and Epidemiology,...
Karolinska Institutet

Completed

HIV Vertical Transmission in Vietnam

HIV Infections

Vietnam
Institut Pasteur
Institut Pasteur de Bangui

Active, not recruiting

A One Health Study of Monkeypox Human Infection (AFRIPOX)

Monkeypox Virus Infection

Central African Republic
Institut Claudius Regaud
Institut Paoli-Calmettes

Active, not recruiting

Therapeutic Nipple Sparing Mastectomy. (MAPAM-01)

Breast Cancer

France
Institut de Myologie, France
Institut Roche

Completed

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy (NatHis-SMA)

Type 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular Atrophy

Belgium, France, Germany
Institut Toulousain d'Ostéopathie
Institut Claudius Regaud

Recruiting

Algology in Oncology Osteopathic Support (ALGOS) (ALGOS)

Breast Cancer | Neuropathic Pain

France
Institut Pasteur
Institut Pasteur de Bangui

Completed

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum (MACOMBA)

HIV Infection | Malaria in Pregnancy

Central African Republic
Miquel Pujol
Institut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III

Terminated

Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia (SAFO)

Methicillin Susceptible Staphylococcus Aureus Septicemia

Spain
ANRS, Emerging Infectious Diseases
Institut Pasteur; National Hepatology & Tropical Medicine Research Institute

Withdrawn

Evaluation of the National Treatment Program of Hepatitis C in Egypt (eNTC)

Chronic Hepatitis C

Egypt
Centre Francois Baclesse
Roche Pharma AG; National Cancer Institute, France; Institut Curie

Completed

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

Metastatic Malignant Neoplasm to Brain

France
Swedish Institute for Infectious Disease Control
MCM Vaccines B.V.; Statens Serum Institut

Unknown

An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster (Tdap Booster)

Pertussis | Tetanus | Diphtheria

Sweden
Paul Scherrer Institut, Center for Proton Therapy
Swiss Federal Institute of Technology

Completed

Assessment of 2 Different Techniques for Suppression of Respiratory Motion in Lung Cancer Treatment With Proton Therapy Using Magnetic Resonance Imaging (MRI)

Healthy Volunteers

Switzerland
Institut Curie

Not yet recruiting

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT) (FAP-IT)

Triple Negative Breast Cancer
Institut Rafael

Recruiting

Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs (THERAPINNOV)

Quality of Life | Oncology | Symptoms and Signs

France
Institut Bergonié

Recruiting

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene (COCO)

PTEN Gene Mutation

France
Institut Curie

Recruiting

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours (BIOPORTAL)

Neuroblastoma | Ganglioneuroblastoma | Ganglioneuroma

France
Institut Bergonié

Not yet recruiting

Remote Monitoring for Ambulatory Care of Elderly Patients With Cancer (TS-PAC)

Cancer
Institut Curie

Recruiting

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) (SALOME)

Uveal Melanoma

France
Institut Pasteur

Recruiting

Role of Nasal Dysbiosis in Parkinson Disease (SMELLPARK)

Parkinson Disease

France, Guadeloupe
Institut Bergonié

Recruiting

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients (PIPER)

Soft Tissue Sarcoma Adult | Solitary Fibrous Tumors | Hemangioendothelioma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Epithelioid Sarcoma | Desmoplastic Round Cell Tumor

France
Institut Curie

Recruiting

Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Retinoblastoma

France
Institut Pasteur

Completed

Conservative Treatment of Catheter - Related Injections With Gentamicine/EDTA (CATH-GE)

Patients With Uncomplicated Long-term Central Venous Catheter-related Biofilm-related Infection

France
Institut Curie

Active, not recruiting

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH) (DepiSCARRH)

Hereditary Retinoblastoma

France
Institut Bergonié

Completed

Health Literacy and Digital Health in Cancer Patients. (LICAPA)

Cancer

France
Institut Rafael

Completed

Screens, Virtual Reality and Digital Addiction (EVADD) (EVADD)

Internet Addiction Disorder

France
Institut Curie

Completed

Study of Circulating Tumoral DNA in Ovarian Cancer

Ovarian Cancer

France
Institut Curie

Completed

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Uveal Melanoma

France
Institut Curie

Terminated

Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)

Metastatic Breast Cancer

France
Institut Curie

Completed

Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange. (CACTuS)

Cancer

France
Institut Curie

Completed

Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma (FibroRect)

Rectum Adenocarcinoma

France
Institut Curie

Completed

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification (PHRCNB07)

Neuroblastoma

France
Institut Curie

Active, not recruiting

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Uveal Melanoma | Melanoma, Uveal

France
Institut Curie

Terminated

FSH-R : Diagnostic Application for Localized Tumors in Cancerology (FRACTal)

Cancer

France
Institut Curie

Completed

Transcutaneous Breast Cancer Diagnosis by Canine Odorology (KDOG1)

Breast Cancer

France
Institut Pasteur

Completed

Genetic & Environmental Determinants Of Immune Phenotype Variance: A Longitudinal Assessment (MI-V3)

Healthy Subjects

France
Institut Curie

Completed

Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4) (BIO-RAIDs)

Cervical Cancer

France, Germany, Netherlands, Romania, Serbia
Institut Curie

Completed

Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial (ES4-UIC)

Metastatic Cancer | Clinical Trial | Supportive Care

France
Institut Curie

Completed

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology (DParcoursDig)

Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma) | Colorectal With Associated Risk Factors

France
Institut Pasteur

Completed

Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets (FIBROTHER)

Fibrosis | Hepatopathy

France
Institut Bergonié

Completed

A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas. (IPSSAR)

Sarcoma

3

Subscribe